#buy-rating
Latest news and interesting information about buy-rating.
Legend Biotech Buy Rating Reiterated
H.C. Wainwright reiterated its Buy rating for Legend Biotech with a $50 target. Revenue up 56% over twelve months.
H.C. Wainwright Reaffirms Mineralys Buy
H.C. Wainwright reiterated a Buy rating on Mineralys Therapeutics with a $56 price target after positive trial data.
Goldman Sachs Initiates HawkEye 360 with Buy Rating
Goldman Sachs initiates HawkEye 360 with a Buy rating and $42 price target. Company shows 74% revenue growth and 82% gross margins. Read more on Bond.az.
Seaport Starts GE Aerospace Coverage with Buy
Seaport Global Securities starts GE Aerospace coverage with a buy rating and $375 price target, citing aftermarket growth potential.
ThinkEquity Initiates Atlas with Buy
ThinkEquity initiates Atlas Technical Consultants with a Buy rating and $15 target. The firm highlights the value of the Brazil critical-minerals option.
BTIG reiterates Uber Buy rating after Delivery Hero bid
BTIG reaffirms Uber Buy rating with $100 target after Delivery Hero bid. Stock seen as undervalued.
Benchmark Reiterates NetEase Buy
Benchmark reiterates Buy on NetEase after strong Q1 results, citing AI integration and margin expansion.
Datadog stock Buy rating reaffirmed
DA Davidson reaffirms Datadog Buy rating with $250 target, citing AI positioning and long-term growth.
Luxfer Stock Gets Buy Rating on Growth
Freedom Broker initiated coverage on Luxfer Holdings with a buy rating and $22 target. Stock up 42% in past year.
Tamboran Resources Stock Gets Buy Rating from Roth/MKM
Roth/MKM gives Tamboran Resources a Buy rating with $47 target. Strong growth and Beetaloo Basin potential highlighted.
Stifel Initiates Eupraxia with Buy Rating
Stifel initiated coverage on Eupraxia Pharmaceuticals with a Buy rating and $25 target. Diffusphere platform and strong finances highlighted.
Rosenblatt Reiterates Buy Rating for Palantir
Rosenblatt reaffirms Buy rating for Palantir with $225 target. Company visit boosts confidence in long-term growth to $1 trillion market cap.
Alpha Tau Stock Gets Buy Rating, $15 Target
H.C. Wainwright reiterates Buy on Alpha Tau stock with $15 target. Company completes ReSTART trial enrollment.
Guggenheim reiterates Buy rating on Okta stock
Guggenheim reiterates Buy rating on Okta stock with $138 price target. Analysts expect Q1 earnings to beat consensus.
Truist Starts Arcus Biosciences at Buy on RCC Potential
Truist Securities initiates Arcus Biosciences with Buy rating and $35 price target, citing casdatifan's potential in renal cell carcinoma and immunology pipeline.
Revolution stock buy rating from Truist
Truist Securities gives Revolution Medicines a buy rating with a $179 price target. Daraxon's potential and company outlook.
DA Davidson Initiates Unity Bancorp with Buy Rating
DA Davidson initiates Unity Bancorp with buy rating and $68 target. Strong growth outlook and dividend history highlighted.
BTIG Reiterates Boot Barn Buy Rating
BTIG maintains Boot Barn Buy rating and $235 target after Q4 beat. Strong revenue growth and margin performance.
H.C. Wainwright Reiterates Kamada Buy Rating
H.C. Wainwright reaffirms Buy rating on Kamada with $13 target. Kamada expects double-digit revenue growth in 2026.
Jefferies initiates Riot Platforms with buy on AI potential
Jefferies initiates Riot Platforms with buy rating, $37 target. AI potential and data center growth key focuses.
Jefferies initiates Hut 8 stock with buy rating
Jefferies initiates Hut 8 Mining stock with Buy rating and $156 target, citing AI data center deals as key catalysts.
Deutsche Bank Reiterates Robinhood Buy Rating on Strong Deposits
Deutsche Bank reiterates Buy rating on Robinhood stock after strong April deposits. Price target remains $86. Learn more.
...